2-Methoxyestradiol induced bax phosphorylation and apoptosis in human retinoblastoma cells via p38 MAPK activation

Molecular Carcinogenesis

Volumn 51, Issue 7, 2012, Pages 576-585

  Min, Hongbo ^a   Ghatnekar, Gautam S ^b,c   Ghatnekar, Angela V ^b   You, Xiaohong ^a   Bu, Min ^b   Guo, Xinyi ^d   Bu, Shizhong ^b   Shen, Bo ^e   Huang, Qin ^d  

^a 455 Hospital   (China)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c FirstString Research Inc   (United States)

^d SECOND MILITARY MEDICAL UNIVERSITY   (China)

^e NANJING MEDICAL UNIVERSITY   (China)

Author keywords

2 methoxyestradiol; Apoptosis; P38 MAPK; Phospho Bax; Retinoblastoma

Indexed keywords

2 METHOXYESTRADIOL; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN BAX; PROTEIN BCL 2; SMALL INTERFERING RNA; THREONINE;

ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DNA FRAGMENTATION; DNA STRAND BREAKAGE; ENZYME ACTIVATION; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RETINOBLASTOMA;

APOPTOSIS; BASE SEQUENCE; BCL-2-ASSOCIATED X PROTEIN; BLOTTING, WESTERN; CELL LINE, TUMOR; DNA PRIMERS; ENZYME ACTIVATION; ESTRADIOL; HUMANS; MUTAGENESIS, SITE-DIRECTED; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; RETINOBLASTOMA; RNA, SMALL INTERFERING;

EID: 84861839598     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20825     Document Type: Article

References (38)

1. Abramson DH. Retinoblastoma. Pediatr Emerg Casebook 1985; 3: 3-15.
2. Abramson DH. Retinoblastoma: Diagnosis and management. CA Cancer J Clin 1982; 32: 130-140.
3. Orjuela M, Castaneda VP, Ridaura C, et al. Presence of human papilloma virus in tumor tissue from children with retinoblastoma: An alternative mechanism for tumor development. Clin Cancer Res 2000; 6: 4010-4016.
4. Bu S, Blaukat A, Fu X, Heldin NE, Landström M. Mechanisms for 2-methoxyestradiol-induced apoptosis of prostate cancer cells. FEBS Lett 2002; 531: 141-151.
5. Lakhani NJ, Sarkar MA, Venitz J, Figg WD. 2-Methoxyestradiol, a promising anticancer agent. Pharmacotherapy 2003; 23: 165-172.
6. LaVallee TM, Zhan XH, Johnson MS, et al. 2-Methoxyestradiol up-regulates death receptor 5 and induces apoptosis through activation of the extrinsic pathway. Cancer Res 2003; 63: 468-475.
7. Fulda S, Debatin KM. Apoptosis signaling in tumor therapy. Ann NY Acad Sci 2004; 1028: 150-156.
8. Widmann C, Gibson S, Jarpe MB, Johnson GL. Mitogen-activated protein kinase: Conservation of a three-kinase module from yeast to human. Physiol Rev 1999; 79: 143-180.
9. Attalla H, Westberg JA, Andersson LC, Adlercreutz H, Makela TP. 2-Methoxyestradiol-induced phosphorylation of Bcl-2: Uncoupling from JNK/SAPK activation. Biochem Biophys Res Commun 1998; 247: 616-619.
10. Shimada K, Nakamura M, Ishida E, Kishi M, Konishi N. Roles of p38- and c-Jun NH2-terminal kinase-mediated pathways in 2-Methoxyestradiol-induced p53 induction and apoptosis. Carcinogenesis 2003; 24: 1067-1075.
11. Oltval Z, Milliman C, Korsmeyer S. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death. Cell 1993; 74: 609-619.
12. De Angelis PM, Stokke T, Thorstensen L, Lothe RA, Clausen OP. Apoptosis and expression of Bax, Bcl-x, and Bcl-2 apoptotic regulatory proteins in colorectal carcinomas, and association with p53 genotype/phenotype. Mol Pathol 1998; 51: 254-261.
13. Kim BJ, Ryu SW, Song BJ. JNK- and p38 kinase-mediated phosphorylation of Bax leads to its activation and mitochondrial translocation and to apoptosis of human hepatoma HepG2 cells. J Biol Chem 2006; 281: 21256-21265.
14. Finucane DM, Bossy-Wetzel E, Waterhouse NJ, Cotter TG, Green DR. Bax-induced caspase activation and apoptosis via cytochrome c release from mitochondria is inhibitable by Bcl-xL. J Biol Chem 1999; 274: 2225-2233.
15. Chipuk JE, Moldoveanu T, Llambi F, Parsons MJ, Green DR. The BCL-2 family reunion. Mol Cell 2010; 37: 299-310.
16. Gardai SJ, Hildeman DA, Frankel SK, et al. Phosphorylation of Bax Ser184 by Akt regulates its activity and apoptosis in neutrophils. J Biol Chem 2004; 279: 21085-21095.
17. Linseman DA, Butts BD, Precht TA, et al. Glycogen synthase kinase-3beta phosphorylates Bax and promotes its mitochondrial localization during neuronal apoptosis. J Neurosci 2004; 24: 9993-10002.
18. Rago R, Mitchen J, Wilding G. DNA florometric assay in 96-well tissue culture plates using Hoechst 33258 after cell lysis by freezing in distill water. Anal Biochem 1990; 191: 31-34.
19. Vindelöv LL, Christensen IJ, Nissen NI. A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry 1983; 3: 323-327.
20. Bu SZ, Huang Q, Jiang Y, et al. p38 Mitogen-activated protein kinases is required for counteraction of 2-methoxyestradiol to estradiol-stimulated cell proliferation and induction of apoptosis in ovarian carcinoma cells via phosphorylation Bcl-2. Apoptosis 2006; 11: 413-425.
21. Yanagisawa T. Systemic chemotherapy as a new conservative treatment for intraocular retinoblastoma. Int J Clin Oncol 2004; 9: 13-24.
22. Suzuki S, Kaneko A. Management of intraocular retinoblastoma and ocular prognosis. Int J Clin Oncol 2004; 9: 1-6.
23. Pribluda VS, Gubish ER, Jr., Lavallee TM, Treston A, Swartz GM, Green SJ. 2-Methoxyestradiol: An endogenous antiangiogenic and antiproliferative drug candidate. Cancer Metastasis Rev 2000; 19: 173-179.
24. Fukui M, Zhu BT. Mechanism of 2-methoxyestradiol-induced apoptosis and growth arrest in human breast cancer cells. Mol Carcinog 2009; 48: 66-78.
25. Lewis JS, Thomas TJ, Pestell RG, Albanese C, Gallo MA, Thomas T. Differential effects of 16α-hydroxyestrone and 2-methoxyestradiol on cyclin D1 involving the transcription factor ATF-2 in MCF-7 breast cancer cells. J Mol Endocrinol 2005; 34: 91-105.
26. Fotopoulou C, Baumunk D, Schmidt S, Schumacher G. Additive growth inhibition after combined treatment of 2-methoxyestradiol and conventional chemotherapeutic agents in human pancreatic cancer cells. Anticancer Res 2010; 30: 4619-4624.
27. Tevaarwerk AJ, Holen KD, Alberti DB, et al. Phase I trial of 2-methoxyestradiol NanoCrystal dispersion in advanced solid malignancies. Clin Cancer Res 2009; 15: 1460-1465.
28. Dahut WL, Lakhani NJ, Gulley JL, et al. Phase I clinical trial of oral 2-methoxyestradiol, an antiangiogenic and apoptotic agent, in patients with solid tumors. Cancer Biol Ther 2006; 5: 22-27.
29. Autret A, Martin SJ. Emerging role for members of the Bcl-2 family in mitochondrial morphogenesis. Mol Cell 2009; 36: 355-363.
30. Czabotar PE, Colman PM, Huang DC. Bax activation by Bim? Cell Death Differ 2009; 16: 1187-1191.
31. Kutuk O, Letai A. Regulation of Bcl-2 family proteins by posttranslational modifications. Curr Mol Med 2008; 8: 102-118.
32. Kuo PL, Chiang LC, Lin CC. Resveratrol-induced apoptosis is mediated by p53-dependent pathway in Hep G2 cells. Life Sci 2002; 72: 23-34.
33. Yu B, Ruman J, Christman G. The role of peripheral gonadotropin-releasing hormone receptors in female reproduction. Fertil Steril 2011; 95: 465-473.
34. Sun S, Li XL, Wang CZ, Williams S, Yuan CS. Improving anticancer activities of Oplopanax horridus root bark extract by removing water-soluble components. Phytother Res 2010; 24: 1166-1174.
35. Bennett MW, O'Connell J, O'Sullivan GC, et al. The Fas counterattack in vivo: Apoptotic depletion of tumor-infiltrating lymphocytes associated with Fas ligand expression by human esophageal carcinoma. J Immunol 1998; 160: 5669-5675.
36. Macleod KF, Sherry N, Hannon G, et al. p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes Dev 1995; 9: 935-944.
37. Sherr CJ. G1 phase progression: Cycling on cue. Cell 1994; 79: 551-555.
38. Sherr CJ, Roberts JM. CDK inhibitors: Positive and negative regulators of G1-phase progression. Genes Dev 1999; 13: 1501-1512.